Follow
Knut Smeland
Knut Smeland
Other namesKnut Bjøro Smeland, Knut B Smeland, Knut Halvor Smeland
Department og Oncology, Oslo University Hospital
Verified email at ous-hf.no - Homepage
Title
Cited by
Cited by
Year
Burkitt lymphoma international prognostic index
AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ...
Journal of clinical oncology 39 (10), 1129-1138, 2021
592021
Heart failure and asymptomatic left ventricular systolic dysfunction in lymphoma survivors treated with autologous stem-cell transplantation: a national cross-sectional study
K Murbraech, KB Smeland, H Holte, JH Loge, MB Lund, T Wethal, E Holte, ...
Journal of Clinical Oncology 33 (24), 2683-2691, 2015
592015
Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: a national cross-sectional study
K Murbraech, T Wethal, KB Smeland, H Holte, JH Loge, E Holte, A Rösner, ...
JACC: Cardiovascular Imaging 9 (3), 230-239, 2016
582016
Impaired right ventricular function in long-term lymphoma survivors
K Murbraech, E Holte, K Broch, KB Smeland, H Holte, A Rösner, MB Lund, ...
Journal of the American Society of Echocardiography 29 (6), 528-536, 2016
342016
Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation
JS Stenehjem, KB Smeland, K Murbraech, H Holte, S Kvaløy, L Thorsen, ...
British journal of cancer 115 (2), 178-187, 2016
322016
Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation
CE Kiserud, UM Fagerli, KB Smeland, Ø Fluge, H Bersvendsen, S Kvaløy, ...
Acta oncologica 55 (5), 547-553, 2016
322016
Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: a Nordic Lymphoma Epidemiology Group Study
JL Biccler, I Glimelius, S Eloranta, KB Smeland, PN Brown, LH Jakobsen, ...
Journal of Clinical Oncology 37 (9), 703-713, 2019
282019
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non‐Hodgkin lymphoma
KB Smeland, CE Kiserud, GF Lauritzsen, AK Blystad, UM Fagerli, RS Falk, ...
British Journal of Haematology 173 (3), 432-443, 2016
272016
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
HS Bersvendsen, HS Haugnes, UM Fagerli, Ø Fluge, H Holte, ...
Acta Oncologica 58 (5), 690-699, 2019
192019
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life
SA Eikeland, KB Smeland, F Mols, UM Fagerli, HS Bersvendsen, ...
Acta Oncologica 60 (7), 911-920, 2021
182021
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
KB Smeland, JH Loge, HCD Aass, T Aspelin, H Bersvendsen, N Bolstad, ...
Bone marrow transplantation 54 (4), 607-610, 2019
152019
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world …
LH Jakobsen, F Ellin, KB Smeland, T Wästerlid, JH Christensen, ...
British journal of haematology 189 (4), 661-671, 2020
142020
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway
KB Smeland, CE Kiserud, GF Lauritzsen, UM Fagerli, RS Falk, Ø Fluge, ...
haematologica 100 (6), e240, 2015
132015
High-dose therapy with autologous stem cell support for lymphoma in Norway 1987–2008
KB Smeland, CE Kiserud, GF Lauritzsen, AK Blystad, UM Fagerli, Ø Fluge, ...
Tidsskrift for Den norske legeforening, 2013
132013
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
HS Bersvendsen, HS Haugnes, AA Dahl, UM Fagerli, Ø Fluge, H Holte, ...
Bone marrow transplantation 55 (5), 891-905, 2020
122020
Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue
A Fosså, KH Smeland, Ø Fluge, KJ Tronstad, JH Loge, Ø Midttun, ...
PloS one 15 (1), e0227384, 2020
122020
High-dose therapy with autologous stem cell support for lymphoma–from experimental to standard treatment
KB Smeland, CE Kiserud, GF Lauritzsen, A Fosså, J Hammerstrøm, ...
Tidsskrift for Den norske legeforening, 2013
112013
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
M Seland, KB Smeland, T Bjøro, RS Falk, SD Fosså, CG Gjesdal, ...
Acta Oncologica 56 (4), 590-598, 2017
102017
Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment
SA Eikeland, KB Smeland, VC Simensen, UM Fagerli, HS Bersvendsen, ...
Acta Oncologica 62 (1), 80-88, 2023
72023
Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
JS Stenehjem, KB Smeland, K Murbraech, H Holte, SO Kvaløy, T Wethal, ...
Acta Oncologica 57 (6), 773-781, 2018
72018
The system can't perform the operation now. Try again later.
Articles 1–20